chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 53-years-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 18Jul2022 at 15:30 as DOSE 4 (BOOSTER), SINGLE (Batch/Lot number: unknown) at the age of 53 years, in left arm for covid-19 immunization; COVID-19 vaccine (COVID-19 VACCINE), as DOSE 1, SINGLE (Batch/Lot number: unknown), as DOSE 2, SINGLE (Batch/Lot number: unknown) and as DOSE 3 (BOOSTER), SINGLE (Batch/Lot number: unknown) for covid-19 immunization. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-COV-2 test: (27Sep2022) Negative, notes: Tested negative yesterday (2 antigen tests), (27Sep2022) Negative, notes: Tested negative yesterday (2 antigen tests); (28Sep2022) Positive, notes: testing very positive again today. Therapeutic measures were taken as a result of drug ineffective, COVID-19.  Clinical information: Patient was healthy with no risk factors. She had no known allergies. She had no other medical history. She had no other medication in two weeks.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
After receiving vaccine, pt states her entire upper arm swelled and she was not able to move arm all weekend. The under arm region also broke out in welts. She iced arm and took pain reliever and arm is just now (9/8) starting to go back to normal. However, still sore. No past rxn. per pt.
Patient positive for COVID-19 on 04/12/21 after completing vaccination. Nonproductive cough and sinus drainage.
About 25 minutes after injecting the vaccines, patient presented with itching feeling everywhere (including eyes & at the injection sites (left thigh), conjunctival injection and swelling of the eyelids. Patient was provided with oral Benadryl, with swelling and itching subsiding. Patient became drowsy (following ten minutes of receiving Benadryl). Emergency services were called due to his pre-existing condition of cyanotic congenital heart disease. Emergency services arrived 40 minutes after the initial adverse event. His vitals were stable and expiration became prolonged. Patient was given Albuterol inhalation by emergency services and was then taken to Hospital.
pt recv vax; joint pain & noc fevers following adm of vax;pain started 2 wk p/ vax; uveitis;JRA;
My adverse events were that I was having trouble breathing, I felt like someone was stepping on my chest consistently, I was coughing a lot, I felt depressed, I had no appetite and felt extremely fatigued. I was admitted to The Emergency room because of high blood sugar so I went back on Lantus and everything has normalized. I was admitted on 06/09/2021 and discharged 06/10/2021. I had blood work drawn and a COVID test. My COVID test came back normal and my blood work showed that my blood sugar was very high.
Coryza/rhinorrhea/fever to 103.7 X 2-3days prior to onset of papular rash that spread from head towards toes.  Diarrhea X 2days. No treatment at this time.  Supportive Care. Patient taking multivitamins daily.
Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Hypertension-Severe, Systemic: Nausea-Medium, Systemic: Numbness (specify: facial area, extremities)-Medium, Systemic: Shakiness-Medium, Systemic: Tingling (specify: facial area, extemities)-Severe, Additional Details: Within 10 minutes of administration patient became very overheated and passed out. I provided and ice pack and cold water to help revive the patient. I monitored the blood pressure which was elevated at 126/93 at the time of the event. I monitored him as he revived and his blood pressure came down to 110/68 then normalized at 118/81. He reported feeling nauseas before he lost consciousness. Conciousness was lost for a matter of seconds. Patient also reported numbness/tingling in both arms.
I discovered a lump on my left thyroid 8 days after my COVID-19 shot and will undergo surgery to remove my thyroid on 06/22/2021.
Approximately 10-11 days after my second vaccine, I began having severe dizzy spells, at times severe enough to make me fall down where I stood.  I fall down at least once per day, and I am 4-5 days into these symptoms.
Erythematous raised area approximately = 4 x 5 in. to (L) upr. arm within 2 days after VARIVAX vaccine & HPV vaccine TDAP to same area 8/20/2010. Currently taking KEFLEX & BENADRYL for cellulitis.
Patient admitted with Encephalopathy and Respiratory Failure.  Patient found to have meningitis.  NEUROLOGIC   Meningitis with Likely Secondary Vasculitis and Acute Ischemic Strokes - Strep pneumo - MRI brain with multiple acute infarctions cortical and subcortical regions bilateral hemispheres - Continue Rocephin  - EVD previously in and subsequently has been discontinued - 4 vessel angio 2/25 without mycotic aneurysm - Secondary to endocarditis    DVST - Goal euvolemia  - Currently heparin drip on hold given psoas muscle hematoma expansion with Hgb drop -> restart 3/3 AM - If further neurologic worsening thought to be secondary to DVST might need to engage NIR if unable to safely anticoagulate   Polysubstance Abuse/Encephalopathy - Oxy weaned to prn - Continue scheduled Zyprexa    HEMATOLOGIC/ ID   Strep Pneumoniae Bacteremia - Continue Rocephin    R Psoas Hematoma - Enlarged in size now with Hgb drop noted overnight 2/27-2/28 and now with slow drop -> now stable - Now s/p 2 U pRBCs with good response - Hemodynamically stable - Currently without concern for active bleeding -> Hgb back to 6.8 and will give another 1 U pRBC -> if further continued drift will need to consider CTA at that time - VIR following - Continue to hold heparin drip for now -> restarted 3/3 AM - Now that Hgb appears to be stable will plan to initiate stroke protocol heparin drip 3/3 AM if remains stable given DVST
Patient reports having typical arm pain for the first couple days, but also noticed headaches and nausea developing over the first 2 days after vaccination. The first 2 nights after the shot, she experienced "extreme" night sweats, noting that she sweat thru her shirt and onto her bed sheets overnight.  By day 4 post-vaccination, she noticed a rash appearing on the arm where the shot was given, which has "doubled" in size since first appearing (over the last day or so). It is about the size of an open hand including the fingers at this point. She reports itchiness around the rash and elsewhere, such as the neck, etc. Over the last several days she has also noticed a loss of appetite, abdominal pain, increased bowel movements, swollen lymph nodes (in the armpits) and general fatigue.  Most of the symptoms are persisting at this point (5 days post-vaccination), except for the headaches, arm soreness, and night sweats.
Severe tinnitus several days after receiving the first vaccine dose. Tinnitus is accompanied by  tension headaches and brain fog.
Around 12;00pm on 3/13 , I  felt muscle aches through back, shoulders, neck.  Sore at site of vaccine and Headache.  I felt tired and rested around 1:00p.m.  Took 1 extra Strength Tylenol.  Then started getting chills.  Felt like I had swollen lymph node on ride side of throat when swallowing and had some pain going up into my ride ear.  These symptoms lasted all evening.  I didn't feel like eating dinner so rested and took 2 extra strength Tylenol at 9:00 p.m. and went to bed.  Woke up early in morning with bad headache so I took another 2 extra strength Tylenol around 6:00am.  I finally started feeling better around 9:00am.
Diabetes; Even after Covid-19 vaccination got covid; Even after covid-19 vaccination got COVID; Even after covid-19 vaccination got COVID, dose 1 on 15Feb2021, Dose 2 on 08Mar2021; Irritable bowel syndrome; Arthritis; Possible injection reaction/few hours after injection fingers went into stiffness where could not even move them; This is a Solicited report from a non-interventional based on the information received by Pfizer from AbbVie manufacture number (21K-163-4160088-00) and (21K-163-4160088-00) . A contactable 56-year-old female consumer patient reported for herself that:  A 56-years-old female patient received first dose of bnt162b2 (BNT162B2,formulation: Solution for injection, Batch/Lot number: unknown), via intramuscular route of administration on 15Feb2021 at the age of 56 years as DOSE 1,SINGLE for covid-19 immunization and on 08Mar2021 ,at the age of 56 years she received second dose of bnt162b2 (BNT162B2,formulation: Solution for injection, Batch/Lot number: unknown), via intramuscular route of administration, as DOSE 2,SINGLE for covid-19 immunization. And ADALIMUMAB(HUMIRA), Solution for injection in pre-filled pen from an unknown date and ongoing, dose description: CF, for Moderate to severe ulcerative colitis. The patient's relevant medical history and concomitant medications were not reported. It was reported that on an unspecified date in 2021, patient experienced Irritable bowel syndrome, Even after Covid-19 vaccination got covid, vaccination failure (Vaccine response impaired) ,Diabetes, Arthritis, Possible injection reaction/few hours after injection fingers went into stiffness where could not even move them and drug ineffective.The patient underwent lab tests and procedures which included SARS-CoV-2 test result positive. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. The outcome of the events Irritable bowel syndrome, Even after Covid-19 vaccination got covid, Diabetes, Arthritis, were reported as not recovered and for events Possible injection reaction/few hours after injection fingers went into stiffness where could not even move them and vaccination failure(Vaccine response impaired) and drug ineffective were reported as unknown.  Causality as per the reporter: Not reported.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.; Sender's Comments: Based on the information in the case report and a plausible temporal relationship, a possible causal association between the events and suspect drug BNT162B2 cannot be excluded.
Dizziness, NauseaVomiting, unable to walk due to dizziness Narrative:  Other Relevant History:
Rash, high fever x 1 days , temperature 106.0 after shot. ?MMR
Within few minutes of administering MMR, the child became limp, cyanotic; mouth to mouth rescusitation. Epiniphrine injection and intubation by paramedics. Diagnosis anaphylactic reaction to MMR. 60-day follow up on 12/03/2003: "Vaccine recipient has recovered from adverse events that were reported for this vaccination."
Fever 102 plus F, chills, headache, cough, muscle aches, flank pain.
Since two days before the second vaccine, I have had my period, which has now been for more than a month. I have a LARC, which has caused me to not have a period prior to this for probably about the last 6 months.
5-10 min. following vaccination, mother noticed reddened, blotchy cheeks and nose. Nose itches. Child alert, oriented, no wheezing, no resp. difficulty. Given H2O and observed x 30 minutes. Released to home w/instructions. F/U call to mother on 11/12/09-no further sxs.
Anaphylaxis, itching, tightness of the throat, shortness of breath, low oxygen levels   Treatment: 1 Benadryl 1130am, 1 Epipen 1155am, 1 Epipen 1225, steroids intravenously 1pm  Outcome: Released home
The product gave the patient shingles, on the right side all the way down, including her groin, front, and back of the legs. Then it travelled to the left side of her body; Her eye was twitching; This spontaneous information has been received from a female patient of unknown age, concerning herself via Agency. The patient's pertinent medical history, concurrent conditions, previously drug reactions, allergies and concomitant medications were not provided.  On 14-JAN-2018, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) for prophylaxis (strength, dose, frequency, route of administration, anatomical location, lot number and expiration date were not reported).  On an unknown date, the patient experienced shingles, on the right side all the way down, including her groin, front and back of the legs, then it travelled to the left side of her body (herpes zoster). On 03-DEC-2020, her eye was twitching (eye movement disorder) and the shingles travelled down her arm and shoulders. It was reported that it had been a severe thing and they would try a new technique in the center of her nervous system. They wanted to put six rods in her body and she would received tapentadol hydrochloride (NUCYNTA) in the emergency room (ER) until she could get the procedure done for the nerve pain she had. At the time of this report, the patient had not recovered from the adverse events.  The reporter considered herpes zoster to be related to zoster vaccine live (ZOSTAVAX). The causal relationship between eye movement disorder and zoster vaccine live (ZOSTAVAX) was not provided.
Dizziness, flu-like symptoms starting 9 hours after flushot and continuing until time of report (24 hours after incident); referred patient to primary care physician. Instructed patient to sit/stand slowly and use caution driving.
With 1-2 hours: Migraine, dizziness, nausea By the next day: swollen and very painful injection site, extremely frequent urination (3-4 X/ hour, ) diarrhea, sore throat, runny nose, confusion, anxiety, forgetfulness, insomnia.
3RD DOSE OF COVID VACCINE GIVEN 5/4/22, MODERNA, #056M21A; pt to ED 9/25/22 with suprapubic pain and difficulty urinating; acute cystitis; pt tested positive earlier in the week for COVID after 2-3 wks of cough; no dyspnea; no other complaints; ABX for UTI; O2 supplementation; Dexamethasone; on dialysis; during hospitalization, pt had low blood pressures; transferred to ICU; worsening oxygenation; bronchoscopy done with slight improvement in oxygenation; during dialysis pt experienced dyspnea and decompensation with hypoxia and hypotension; rapid response called; DNR/DNI; transitioned to comfort care and pt passed away in the hospital
sore arm; balance was off; fatigued; right side started to hurt /pain with bending over / Pain with getting up from toilet; Short of breath; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PAIN (right side started to hurt /pain with bending over / Pain with getting up from toilet), DYSPNOEA (Short of breath), BALANCE DISORDER (balance was off) and FATIGUE (fatigued) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination.     The patient's past medical history included Valley fever (diagnosed prior to receiving the vaccine).    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, the patient experienced PAIN (right side started to hurt /pain with bending over / Pain with getting up from toilet) and DYSPNOEA (Short of breath). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), BALANCE DISORDER (balance was off) and FATIGUE (fatigued). The patient was treated with IBUPROFEN at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (sore arm), PAIN (right side started to hurt /pain with bending over / Pain with getting up from toilet), DYSPNOEA (Short of breath), BALANCE DISORDER (balance was off) and FATIGUE (fatigued) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported by reporter.  It was reported that the patient had been diagnosed with "Valley Fever" prior to receiving the vaccine. She was put on a medication (not specified) which made her feel fatigued and like her balance was off. Her fatigue and balance both worsened since she received the vaccine.  Upon follow up, patient stated she was doing fine.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: TCR received, outcome of events/patient history/narrative updated; declined follow-up.
6 mths severe pain in left shoulder, numbness and tingling in feet stiff neck, poor balance. On going Dr. visits treated with steroids. Had symptoms about 6 mths until treated with steroids.
Client contacted and informed me on 7/22/21 that her are was red, itchy and a little swollen.  Reminded her about taking Benadryl, cool/warm compress to the site.  Did a follow-up with her and stated had noticed lumps under her arm and that she had and appointment to see a doctor concerning the matter. I agreed that would be the best thing to do. Did a follow-up again and stated physician gave medication for the swollen lymph nodes.  a follow-up again made  and stated the medication helped with the swollen lymph nodes and that her arm was better and the swollen lymph nodes were gone.
Patient came to clinic on 8/13/20 with c/o reaction to vaccine injections given on 8/11/20. Both vaccines where given in the right deltoid. I observed a red raised band around upper right arm about 2 in below shoulder extending to just 2 in above elbow.
This is a spontaneous report from a contactable nurse, reporting for herself. This 50 year-old female patient receive a single dose of  PREVNAR 13 via an unspecified route of administration on 17Nov2016 for immunization. Medical history was reported as none.  The patient's concomitant medications were not reported.  On 17Nov2016 the patient experienced a local skin reaction and she was sick.  The patient underwent unspecified laboratory tests on an unspecified day in Nov2016.  In response to the events the patient took diphenhydramine hydrochloride (BENADRYL) over the weekend. The patient was not recovered at the time of this report. The events were considered as related to the vaccination.
Cough , Chest congested cough; Fever 100F in one ear, 101F in another; Headache, congested; Chill; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough , Chest congested cough), PYREXIA (Fever 100F in one ear, 101F in another), HEADACHE (Headache, congested) and CHILLS (Chill) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced COUGH (Cough , Chest congested cough), PYREXIA (Fever 100F in one ear, 101F in another), HEADACHE (Headache, congested) and CHILLS (Chill). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, COUGH (Cough , Chest congested cough), PYREXIA (Fever 100F in one ear, 101F in another), HEADACHE (Headache, congested) and CHILLS (Chill) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported
after injection immediately started itching then broke out into hives; after injection immediately started itching then broke out into hives; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 31 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 10Sep2021 07:15 (Lot number: EW0176) at the age of 31 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "PCOS" (unspecified if ongoing); "Allergies: Eggs" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Allergies: sulfur, reaction(s): "Drug allergy". The following information was reported: PRURITUS (non-serious), URTICARIA (non-serious) all with onset 10Sep2021, outcome "recovered" (Sep2021) and all described as "after injection immediately started itching then broke out into hives". The event "after injection immediately started itching then broke out into hives" and "after injection immediately started itching then broke out into hives" was evaluated at the physician office visit. Therapeutic measures were not taken as a result of pruritus, urticaria.  Additional information: Facility where the most recent COVID-19 vaccine was administered was Workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID, Prior to vaccination, the patient was not diagnosed with COVID-19 and Since the vaccination, was not tested for COVID-19. After injection immediately started itching then broke out into hives.  No follow-up attempts are possible. No further information is expected.
This spontaneous case reported by a consumer, describes the occurrence of accidental overdose (received a full 100mcg dose for her first booster dose) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 039K202A) for COVID-19  immunization. No medical history reported. On Jan 17, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Feb 14, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient received the third dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 100 microgram. On an unknown date, patient experienced accidental overdose (received a full 100mcg dose for her first booster dose). At the time of the report, accidental overdose (received a full 100mcg dose for her first booster dose) outcome: unknown. Patient not immunocompromised. No concomitant medication or treatment information reported. This case linked to MOD-2022-529115 (patient link).
Chills, body aches, severe headache, extreme fatigue for 24 hours starting approximately 12 hours after injection.  Exact same reaction as the first vaccine.  Onset was sudden and acute as was the resolution.
I have severe chest pain. I can't breathe fully and I am out of breath very quickly. My chest feels very tight all of the time and my pain doesn't subside. I never experienced this before being vaccinated. I am healthy, young, and have no prior health conditions. I am visiting my primary care physician on November 11th to seek help and get an action plan. It is hard for me to walk or run over a short distance without experiencing chest pain.
Observed redness to the area of the injection site approximately 7 days after the injection.  The site was warm to the touch.